Cardinal Health, Inc. (NYSE: CAH) has posted a slight gain in its latest trading session, reflecting modest investor optimism. With a market capitalization of $45.4 billion and steady dividend payouts, the company remains a notable entity in the healthcare distribution sector.
Company Overview
Founded in 1979 and headquartered in Dublin, Ohio, Cardinal Health, Inc. operates across the United States and internationally. The firm delivers integrated healthcare services and products under two primary segments: Pharmaceutical and Medical. It serves hospitals, healthcare systems, pharmacies, ambulatory surgery centers, laboratories, physician offices, and home-based patients.
The Pharmaceutical segment distributes branded and generic products, specialty pharmaceuticals, and over-the-counter healthcare goods. It also operates nuclear pharmacies and radiopharmaceutical facilities, provides medication therapy management, and pharmacy management services.
The Medical segment manufactures, sources, and distributes medical, surgical, and laboratory products, along with assembling sterile and non-sterile procedure kits. Products range from gloves and needles to wound care and nutritional delivery solutions.
Stock Performance
On its latest trading day, Cardinal Health closed at USD 190.77, an increase of 0.93 points or 0.49% from the previous close. This movement, though moderate, signals a degree of investor confidence in the stock’s stability.
The 52-week range of USD 110.63 to USD 197.67 illustrates a strong upward trend in recent months. Volume reached 3,143,368 shares, exceeding the average daily volume of 2,456,371 shares. Elevated volume can reflect heightened interest and liquidity in the stock, allowing investors more flexibility in entering or exiting positions.
Market Position and Sector
Cardinal Health is part of the Healthcare sector, specifically the Medical – Distribution industry. The company’s market capitalization of over $45 billion underscores its significant standing among healthcare service providers. Its scale offers resilience in competitive markets and positions it to benefit from trends in pharmaceutical demand and medical supply chains.
Governance and Leadership
The organization is led by CEO Jason M. Hollar. Strong governance and experienced leadership are critical in navigating regulatory compliance and industry changes, especially in sectors deeply connected to patient safety and healthcare policy.
Key Financial Data
Cardinal Health’s last declared dividend stands at USD 2.0326 per share. Dividends provide shareholders with direct returns and can be an indicator of corporate stability and profitability.
- Price: USD 190.77
- Market Cap: USD 45,404,010,489
- Dividend: USD 2.0326 per share
- 52-week Range: USD 110.63 – 197.67
- Volume: 3,143,368 shares
- Average Volume: 2,456,371 shares
Trading Details
Cardinal Health is listed on the New York Stock Exchange under the symbol CAH. It carries the ISIN US14149Y1082 and CUSIP 14149Y108. These identifiers help investors accurately track securities across different markets.
FAQ
- What is the company’s dividend policy? Cardinal Health pays an annual dividend of USD 2.0326 per share, reviewed and declared by its board.
- Where is the company headquartered? The headquarters is in Dublin, Ohio, USA.
- How many full-time employees does the company have? Cardinal Health employs approximately 47,922 people globally.
- On which exchange is CAH traded? The stock is traded on the New York Stock Exchange.
- What sector does the company belong to? The firm operates in the Healthcare sector, specifically medical distribution.
Conclusion
Cardinal Health’s current trading data reflects steady market confidence and a strong operational base. Its market position and diversified service portfolio offer resilience. Investors may view the stable dividend and high market capitalization as signals of strength, but should always consider broader market conditions before making decisions.
Disclaimer
This article is for informational purposes only and does not constitute financial advice. Investors should conduct independent research or consult a professional before acting on market data.
Official Source
For full information about the company, see the link below.
https://www.cardinalhealth.com